REM Sleep Behavior Disorder and Neurodegenerative Risk
A 65-year-old man presents with a 2-year history of violent dream enactment behaviors during sleep, including punching and kicking, which have injured his wife. He recalls vivid dreams of being chased. He has no known neurological disease but reports mild constipation and decreased sense of smell. His physical examination is normal except for mild rigidity in the right arm. He undergoes a polysomnogram that shows REM sleep without atonia, confirming REM sleep behavior disorder (RBD). He is concerned about his risk of developing Parkinson's disease.
1. What is the most appropriate initial management for his RBD?
Read the worked answer
The most appropriate initial management for RBD is to ensure safety for the patient and bed partner. This includes environmental modifications (e.g., removing dangerous objects from the bedroom, placing mattress on floor, using separate beds) and pharmacologic therapy. Melatonin (3-12 mg at bedtime) is first-line due to its favorable safety profile. Clonazepam is also effective but carries risks of sedation, falls, and cognitive impairment, especially in older adults. Therefore, melatonin should be initiated, along with safety counseling.
2. How would you counsel him about his risk of developing a neurodegenerative disease, and what follow-up is appropriate?
Read the worked answer
Idiopathic RBD is a strong prodromal marker for synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Approximately 50-80% of patients develop a neurodegenerative disorder within 10-15 years. The patient should be informed of this risk in a sensitive manner. Follow-up should include regular neurological examinations to monitor for motor and cognitive symptoms, and consideration of biomarkers (e.g., dopamine transporter imaging, MIBG scintigraphy) if available, though these are not routine. Management should focus on symptom control and safety. Therefore, counseling should include the high risk of conversion and the need for periodic neurological evaluation.